Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure

Potential Nephrotoxicity of Lisinopril and Valsartan on Patients with Congestive Heart Failure

Lisinopril (angiotensin converting enzyme inhibitor) and valsartan (angiotensin II receptor blocker) are the first-line treatment for patients with congestive heart failure (CHF). These two drugs potentially cause side effects on renal functions. However, limited information was available regardi...

Full description

Bibliographic Details
Main Authors:	Sarini Pani, Melisa I. Barliana, Eli Halimah, Venice Chaeriadi, Mally G. Sholih
Format:	Article
Language:	English
Published:	Universitas Padjadjaran 2017-04-01
Series:	Pharmacology and Clinical Pharmacy Research

Similar Items

Pharmacoeconomic analysis of valsartan for the treatment of chronic congestive heart failure in Italy
by: Sergio Iannazzo, et al.
Published: (2008-09-01)

Influence of Lisinopril and Losartan on Parameters of Cardiac Hemodynamics and Kidney Function in Patients with Congestive Heart Failure
by: Zulfiya D. Rasulova, et al.
Published: (2014-12-01)

Valsartan and lisinopril influence on brachial artery endothelial function in patients with Q-wave acute myocardial infarction
by: M. M. Kremkova, et al.
Published: (2005-02-01)

Effectiveness of sacubitril–valsartan in cancer patients with heart failure
by: Ana Martín‐Garcia, et al.
Published: (2020-04-01)

Congestive heart failure
by: Burton, G. E.
Published: (1946)

The effects of valsartan on renal glutathione peroxidase expression in alleviation of cyclosporine nephrotoxicity in rats
by: Sina Raeisi, et al.
Published: (2016-09-01)

Eligibility for sacubitril–valsartan in patients with acute decompensated heart failure
by: David Carballo, et al.
Published: (2020-06-01)

Sacubitril/valsartan: An important piece in the therapeutic puzzle of heart failure
by: Pedro Marques da Silva, et al.
Published: (2017-09-01)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
by: Alex Heyse, et al.
Published: (2019-12-01)

Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
by: Peter P Liu, et al.
Published: (2006-03-01)

Use of Valsartan in Post-Myocardial Infarction and Heart Failure Patients
by: Peter P Liu, et al.
Published: (2006-03-01)

Renal protective effect of sacubitril/valsartan in patients with heart failure
by: Hui-Ling Hsieh, et al.
Published: (2021-02-01)

Optimal Usage of Sacubitril/Valsartan for the Treatment of Heart Failure: The Importance of Optimizing Heart Failure Care in Canada
by: Ashlay A. Huitema, MD, FRCPC, et al.
Published: (2020-09-01)

Pacing in congestive heart failure
by: Frenneaux Michael P, et al.
Published: (2000-10-01)

Congestive Heart Failure in the Elderly
by: Chiung-Zuan Chiu, et al.
Published: (2007-12-01)

THE SPECIFIC FEATURES OF HEART AND VESSELS REMODELING IN PATIENTS WITH CHRONIC HEART FAILURE TREATED WITH LISINOPRIL DURING 6 MONTHS
by: N. A. Kosheleva, et al.
Published: (2016-01-01)

Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
by: Cuthbert JJ, et al.
Published: (2020-08-01)

Sacubitril/Valsartan for Heart Failure: Exciting Times but Are Doctors Informed and Ready?
by: Prithwish Banerjee
Published: (2017-01-01)

Profile of sacubitril/valsartan in the treatment of heart failure: patient selection and perspectives
by: Yandrapalli S, et al.
Published: (2017-10-01)

COMPARISON OF LOSARTAN AND LISINOPRIL EFFECTIVENESS FOR GLOMERULAR AND TUBULAR MARKERS OF RENAL DYSFUNCTION IN CHRONIC HEART FAILURE
by: U. K. Kamilova, et al.
Published: (2015-04-01)

Prescription of Sacubitril/Valsartan in Patients with Heart Failure and Reduced Ejection Fraction Attending an Outpatient Heart Failure Clinic
by: M Rizzo, et al.
Published: (2020-05-01)

Retraction Note: The effects of valsartan on renal glutathione peroxidase expression in alleviation of cyclosporine nephrotoxicity in rats
by: Sina Raeisi, et al.
Published: (2016-12-01)

Comparison of effectiveness of therapy with lisinopril and fosinopril in patients with diastolic chronic heart failure in the presence of hypertension disease
by: Svetlana N Merzlyakova, et al.
Published: (2019-06-01)

Use of Sacubitril/valsartan in patients with cardio toxicity and heart failure due to chemotherapy
by: Vanesa Gregorietti, et al.
Published: (2020-11-01)

Valsartan in the treatment of heart failure or left ventricular dysfunction after myocardial infarction
by: Naylin Bissessor, et al.
Published: (2007-09-01)

Effects of Sacubitril/Valsartan on Serum Lipids in Heart Failure With Preserved Ejection Fraction
by: Senthil Selvaraj, et al.
Published: (2021-09-01)

Sacubitril/Valsartan in everyday clinical practice: the experience of a heart failure clinic
by: Joana Maria Teixeira Cabral
Published: (2021)

Combination of ivabradine and sacubitril/valsartan in patients with heart failure and reduced ejection fraction
by: Ying‐Hsiang Lee, et al.
Published: (2021-04-01)

Peritoneal dialysis in congestive heart failure
by: Abirami Krishnan, et al.
Published: (2017-04-01)

Update in cardiomyopathies and congestive heart failure
by: The Heart Hospital, London, UK and Monaldi Hospital, Naples, Italy
Published: (2012-05-01)

Congestive heart failure: A history
by: Rachel Hajar
Published: (2019-01-01)

Congestive Heart Failure in Diphtheric Myocarditis
by: A. M. Prasodo, et al.
Published: (2019-09-01)

CONGESTIVE HEART FAILURE: EXPERIMENTAL MODEL
by: Antonio Francesco Corno, et al.
Published: (2013-10-01)

Biventricular Pacing in Congestive Heart Failure
by: Balbir Singh
Published: (2002-04-01)

Psychosomatic Aspects of Congestive Heart Failure
by: Oleg Yu. Shiryaev, et al.
Published: (2017-09-01)

Hypopituitarism presenting as congestive heart failure
by: S Giri, et al.
Published: (2017-01-01)

Potential Role of Thermal Therapy as an Adjunct Treatment in Congestive Heart Failure
by: Hosein Vakili, et al.
Published: (2009-09-01)

Potential Role of Thermal Therapy as an Adjunct Treatment in Congestive Heart Failure
by: Habibollah Saadat, et al.
Published: (2009-07-01)

Clinical and Humoral Determinants of Congestion in Heart Failure: Potential Role of Adiponectin
by: Luca Monzo, et al.
Published: (2019-09-01)

Diminished heart beat nonstationarities in congestive heart failure
by: Sabrina eCamargo, et al.
Published: (2013-05-01)

Cannot write session to /tmp/vufind_sessions/sess_e39b07hgbe9aogl8492eh2mmqr